GI Innovation
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $72M
Investors
- 15
About GI Innovation
Based in Seoul, South Korea and founded in 2017, GI Innovation, Inc. operates as a bio-venture company that develops treatments for immuno-oncology, inflammation, and immunology diseases., Ltd. has established GI-SMART™ platform technology that is designed to accelerate the development of biologics through the optimization of multi-targeting fusion protein therapeutics with high quality and high productivity. GI Innovation, Inc. has been certified by the International Standard Information Protection in 2021., Ltd., NH Investment & Securities, and SK Group. The company's platform technology GI-SMART™ is being used to develop its projects on multi-targeting fusion protein therapeutics namely; GI-101, GI-301, GI-10N, GI-30, and GI-20N.'s main pipeline is GI-101, an immuno-cancer drug, and GI-301, an allergy treatment, produced using its own platform, and GI-SMART technology. The company gained KRW 900 billion worth through the technology transfer of GI-101 to Simcere, one of China's top 10 innovative pharmaceutical companies in 2019.4 trillion., which is pursuing a special listing for its growth potential, plans to submit a request for a preliminary examination on the KOSDAQ and initiate an IPO (public disclosure) in the first half of 2021.
Who invested in GI Innovation
15 investors across 3 rounds
See all investors in GI Innovation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GI Innovation
Who invested in GI Innovation?
GI Innovation has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GI Innovation raised?
GI Innovation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GI Innovation last raise money?
GI Innovation's most recent round on record is a Series C, in Mar 2020.
What does GI Innovation do?
Based in Seoul, South Korea and founded in 2017, GI Innovation, Inc.
Where is GI Innovation headquartered?
GI Innovation is headquartered in Seoul, South Korea.
Which VCs invest in companies like GI Innovation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at GI Innovation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like GI Innovation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.